Evidence map›Paper›PMID 34615577›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2021

Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

G B Migliori, F M Marx, N Ambrosino, E Zampogna, H S Schaaf, M M van der Zalm, B Allwood, A L Byrne, K Mortimer, R S Wallis and 49 more

3 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 119 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 4 pooled it
17.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06127641 narecruitingnot on this mapstarted 2023, after this paper: background citation

Rehabilitation of People With Post-tuberculosis Lung Disease

TypeinterventionalSponsorCentro Universitário Augusto MottaRan2023 to 2027Enrolled40ConditionsPulmonary TuberculosisArmsStandard care plus pulmonary rehabilitation, Standard Care
NCT07067528 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Feasibility and Acceptability of a Diagnostic Algorithm for Timely Post-tuberculosis Lung Disease Diagnosis at Primary Health Care Facilities in Mbarara, Uganda.

TypeinterventionalSponsorMbarara University of Science and TechnologyRan2026 to 2029Enrolled80ConditionsPost Pulmonary Tuberculosis, Post-Tuberculous BronchiectasisArmsA novel PTLD clinical diagnostic algorithm
NCT07097961 narecruitingnot on this mapstarted 2025, after this paper: background citation

Paediatric Post-TB Home-based Pulmonary Rehabilitation Feasibility Study

TypeinterventionalSponsorUniversity of IowaRan2025 to 2026Enrolled40ConditionsTuberculosis in Children, Chronic Lung Disease, Post TuberculosisArmsPulmonary Rehabilitation
3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 4 syntheses or guidelines pooled it, 167 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis.American journal of respiratory and critical care medicine · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. The ghost of tuberculosis past.Nature medicine · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

59 authors at 20 institutions in 24 countries.

G B MiglioriRespiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
F M MarxDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, DSI-NRF South African Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
N AmbrosinoDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri IRCCS, Montescano (PV), Italy.
E ZampognaDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
H S SchaafDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
M M van der ZalmDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
B AllwoodDivision of Pulmonology, Department of Medicine, Stellenbosch University & Tygerberg Hospital, South Africa.
A L ByrneHeart Lung Clinic St Vincent´s Hospital and Clinical School, University of New South Wales, Sydney, NSW, Australia, Partners In Health (Socios En Salud Sucursal), Lima, Peru.
K MortimerLiverpool School of Tropical Medicine, Liverpool, UK.
R S WallisAurum Institute, Johannesburg, South Africa.
G J FoxFaculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
C C LeungHong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong.
J M ChakayaDepartment of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
B SeaworthHeartland National TB Center of Excellence, San Antonio, TX, University of Texas Health Science Center, Tyler, TX, USA.
A RachowDivision of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany, German Center for Infection Research (DZIF), Partner Site Munich, Germany.
B J MaraisThe Children´s Hospital at Westmead and the University of Sydney WHO Collaborating Center in Tuberculosis, University of Sydney, Sydney, NSW, Australia.
J FurinHarvard Medical School, Department of Global Health and Social Medicine, Boston, MA, USA.
O W AkkermanUniversity of Groningen, University Medical Center Groningen, department of Pulmonary diseases and Tuberculosis, Groningen, the Netherlands, University of Groningen, University Medical Center Groningen, TB center Beatrixoord, Groningen, the Netherlands.
F Al YaquobiTB and Acute Respiratory Diseases Section, Department of Communicable Diseases, Directorate General of Disease Surveillance and Control, Ministry of Health, Oman.
A F S AmaralNational Heart and Lung Institute, Imperial College London, London, UK.
S BorisovMoscow Research and Clinical Center for Tuberculosis Control, Moscow Health Department, Moscow, Russian Federation.
J A CamineroMycobacterial Unit, Pneumology Department. University General Hospital of Gran Canaria "Dr. Negrin", Las Palmas, Gran Canaria, ALOSA TB Academy, Spain.
A C C CarvalhoLaboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.
D ChesovDepartment of Pneumology and Allergology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
L R CodecasaTB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy.
R C TeixeiraNational Institute of Respiratory Diseases and the Environment (INERAM), Asunción, Paraguay, Radboud University Medical Center, TB Expert Center Dekkerswald, Department of Respiratory Diseases, Nijmegen - Groesbeek, The Netherlands.
M P DalcolmoReference Center Hélio Fraga, Fundação Oswaldo Cruz (Fiocruz), Ministry of Health, Rio de Janeiro, RJ, Brazil.
S DattaDepartment of clinical sciences, Liverpool School of Tropical Medicine, Liverpool, UK, Innovation For Health And Development (IFHAD) Laboratory for Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru, Innovacion Por la Salud Yel Desarollo, (IPSYD) Asociación Benéfica PRISMA, Lima, Peru.
A-T Dinh-XuanUniversité de Paris, APHP Centre, Lung Function Unit, Department of Respiratory Diseases, Cochin Hospital, Paris, France.
R DuarteInstitute of Public Health, Porto University; Medical School, Porto University; Hospital Centre of Vila Nova de Gaia/Espinho, Porto, Portugal.
C A EvansInnovation For Health And Development (IFHAD) Laboratory for Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru, Innovacion Por la Salud Yel Desarollo, (IPSYD) Asociación Benéfica PRISMA, Lima, Peru, Department of Infectious Diseases, Imperial College London, London, UK.
J-M García-GarcíaTuberculosis Research Programme SEPAR, Barcelona, Spain.
G GüntherDepartment of Pulmonology, Inselspital Bern, University of Bern, Switzerland.
G HoddinottDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
S HuddartUCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, UCSF Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA.
O IvanovaDivision of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany, German Center for Infection Research (DZIF), Partner Site Munich, Germany.
R Laniado-LaborínClínica de Tuberculosis, Hospital General Tijuana, Universidad Autónoma De Baja California, Mexico.
S MangaMedecins Sans Frontieres (MSF), Operational Center, Paris, France.
K ManikaPulmonary Department, Aristotle University of Thessaloniki, "G. Papanikolaou" Hospital, Thessaloniki, Greece.
A MariandyshevNorthern State Medical University, Northern Arctic Federal University, Arkhangelsk, Russian Federation.
F C Q MelloThoracic Diseases Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
S G MpagamaKibong´oto Infectious Diseases Hospital, Kilimanjaro Christian Medical University College, Moshi Kilimanjaro, Tanzania.
M Muñoz-TorricoTuberculosis Clinic, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City.
P NahidUCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, UCSF Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA.
C W M OngInfectious Disease Translational Research Programme, Department of Medicine, National University of Singapore, Yong Loo Lin School of Medicine, Singapore, National University of Singapore Institute for Health Innovation & Technology (iHealthtech), Singapore.
D J PalmeroPulmonology Division, Municipal Hospital F.J. Muñiz and Instituto Vaccarezza, Buenos Aires, Argentina.
A PiubelloDamien Foundation, Brussels, Belgium.
E PontaliDepartment of Infectious Diseases, Galliera Hospital, Genoa, Italy.
D R SilvaFaculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
R SinglaDepartment of TB and Respiratory Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
A SpanevelloDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy, Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Tradate, Varese-Como, Italy.
S TiberiDepartment of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK, Blizard Institute, Queen Mary University of London, London, UK.
Z F UdwadiaDepartment of Respiratory Medicine, Hinduja Hospital & Research Center, Mumbai, India.
M VitaccaRespiratory Unit, Istituti Clinici Scientifici Maugeri IRCCS, Lumezzane (BS), Italy.
R CentisRespiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
L D AmbrosioPublic Health Consulting Group, Lugano, Switzerland.
G SotgiuClinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
C LangeDivision of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany, German Center for Infection Research (DZIF), Clinical Tuberculosis Unit, Borstel, Germany, Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany.
D ViscaDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy, Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Tradate, Varese-Como, Italy.
University of Groningen · NLIstituti Clinici Scientifici Maugeri · ITStellenbosch University · ZAGerman Center for Infection Research · DELiverpool School of Tropical Medicine · GBThe University of Sydney · AUAssistance Publique – Hôpitaux de Paris · FRAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITCentro Hospitalar de Vila Nova de Gaia · PTFundação Oswaldo Cruz · BRG. Papanikolaou General Hospital · GRHarvard University · USHong Kong Tuberculosis, Chest and Heart Diseases Association · CNHospital Muñiz · ARHospital Universitario de Gran Canaria Doctor Negrín · ESImperial College London · GBKilimanjaro Christian Medical Centre · TZMédecins Sans Frontières · FRMinistry of Health · OMNational University of Singapore · SG

Funding

Medical Research Council MR/K007467/1Medical Research Council MR/T040165/1Wellcome Trust 201251/Z/16/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung DiseasesQuality of LifeTuberculosisConsensusHumans

Identifiers

PMID34615577
PMCPMC8504493
OpenAlexW3203672718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.